Medicinova (MNOV) Accumulated Expenses (2010 - 2025)

Medicinova (MNOV) has 16 years of Accumulated Expenses data on file, last reported at $2.6 million in Q4 2025.

• On a quarterly basis, Accumulated Expenses rose 56.84% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 56.84% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 56.84% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $2.6 million, up from $1.9 million in the prior quarter.
• Over the last five years, Accumulated Expenses for MNOV reached as high as $3.8 million in Q3 2022 and fell as low as $636481.0 in Q4 2021.
• Historically, Accumulated Expenses has averaged $1.8 million across 5 years, with a median of $1.8 million in 2021.
• Across the five-year window, Accumulated Expenses tumbled 54.25% in 2021 and jumped 122.09% in 2022, its largest moves.
• Year by year, Accumulated Expenses stood at $636481.0 in 2021, then surged by 44.57% to $920166.0 in 2022, then decreased by 10.41% to $824390.0 in 2023, then jumped by 101.71% to $1.7 million in 2024, then surged by 56.84% to $2.6 million in 2025.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $2.6 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.